Zimmer Biomet will commercialize RevelAi’s artificial intelligence-powered care management platform, care team dashboard and future products. RevelAi’s products help streamline care workflows while addressing healthcare disparities, Christian Péan, MD, CEO of RevelAi Health, said in a June 12 news release.
“Our AI-enabled asynchronous care model delivers personalized, timely, and effective patient care while reducing clinician burnout,” he said. “Our collaboration with Zimmer Biomet is a significant step towards ensuring that every patient receives the care they deserve.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
